IRWD

Ironwood Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 8/10
  • Value↑ 7/10
Ironwood Pharmaceuticals sales and earnings growth
IRWD Growth
Good
  • Revenue Y/Y↓ -15.72%
  • EPS Y/Y↑ 1400.00%
  • FCF Y/Y↑ 22.83%
Ironwood Pharmaceuticals gross and profit margin trends
IRWD Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ 8.10%
  • ROIC 5Y↑ -24.42%
Ironwood Pharmaceuticals net debt vs free cash flow
IRWD Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 3.0
  • Interest coverage↓ 3.1

Ironwood Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗